PHI news
The article highlights the lessons learned from the COVID-19 pandemic and their influence on preparations for future public health emergencies. While the federal Public Health Emergency for COVID-19 is set to end in May 2023, the FDA emphasizes the continued importance of COVID-19 vaccines and treatments. Addressing misinformation and strengthening supply chain resilience are key priorities, and the FDA is developing more efficient inspection planning systems. Modernizing FDA authorities and maintaining a commitment to planning for the future are also emphasized to enhance national security and public health preparedness.
Resource Details
- Setting/Context of Implementation: Clinical|Community
- Topics of Practice: Policy Change/ Development
- Outcomes of Interest: Capacity Building
- Level of Evidence: Emerging
- Tools or Materials Included in Resource: No
- Social Determinants of Health: Healthcare Access and Quality|Social and Community Context
- Outside of US: No